These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 16521392)
1. Federal appeals court says no to first amendment claim in telemarketing case. Sfikas PM J Am Dent Assoc; 2006 Feb; 137(2):241-2. PubMed ID: 16521392 [No Abstract] [Full Text] [Related]
2. Patient solicitation and the First Amendment. Protection of 'commercial speech' at issue in court cases. Sfikas PM J Am Dent Assoc; 2001 Apr; 132(4):532-4. PubMed ID: 11315383 [No Abstract] [Full Text] [Related]
4. The future of off-label marketing regulations in the post-Sorrell era. Iraggi J Seton Hall Law Rev; 2013; 43(3):1137-63. PubMed ID: 23802338 [No Abstract] [Full Text] [Related]
5. [Announcement of an advertised medical practice in the branch telephone book. Decision of the Federal Administrative Court on November 13, 1997]. Rieger HJ Dtsch Med Wochenschr; 1998 Jul; 123(30):918-21. PubMed ID: 9711176 [No Abstract] [Full Text] [Related]
6. The Supreme Court checks out drug promotion restrictions. Gilhooley M Food Drug Law J; 2003; 58(3):347-52. PubMed ID: 14626982 [No Abstract] [Full Text] [Related]
7. [Press reports about physicians and medical advertising ban. Decision of the federal constitutional court on February 11, 1992]. Rieger HJ Dtsch Med Wochenschr; 1992 Sep; 117(37):1413-6. PubMed ID: 1516539 [No Abstract] [Full Text] [Related]
8. Regulation of health services advertising. Barney DR Hosp Health Serv Adm; 1983; 28(3):85-110. PubMed ID: 10299216 [No Abstract] [Full Text] [Related]
9. Healthcare advertising: what you can and cannot say. Barney DR Healthspan; 1985 Jan; 2(1):3-10. PubMed ID: 10271480 [No Abstract] [Full Text] [Related]
10. FTC regulation of health care advertising: when providers deceive. Buc NL; Hofkin LA Healthspan; 1992 Oct; 9(9):3-6. PubMed ID: 10122717 [No Abstract] [Full Text] [Related]
11. A global view of the First Amendment constraints of FDA. Carver KH Food Drug Law J; 2008; 63(1):151-215. PubMed ID: 18561459 [No Abstract] [Full Text] [Related]
12. Claim substantiation in the health care industry. Fergenson PE Hosp Mater Manage Q; 1992 May; 13(4):20-6. PubMed ID: 10117377 [No Abstract] [Full Text] [Related]
13. Legal guidelines to health services marketing: issues & checklists. Berning RK J Health Care Mark; 1983; 3(2):47-9. PubMed ID: 10261799 [No Abstract] [Full Text] [Related]
14. The First Amendment and public health, at odds. Mermin SE; Graff SK Am J Law Med; 2013; 39(2-3):298-307. PubMed ID: 23815033 [No Abstract] [Full Text] [Related]
16. Marketing pharmaceuticals: a constitutional right to sell prescriber-identified data? Gostin LO JAMA; 2012 Feb; 307(8):787-8. PubMed ID: 22357827 [No Abstract] [Full Text] [Related]
17. The tobacco industry and the First Amendment: an analysis of the 1998 Master Settlement Agreement. Luka LA J Law Health; 1999-2000; 14(2):297-319. PubMed ID: 11499160 [No Abstract] [Full Text] [Related]
18. Avoiding the legal pitfalls of testimonials and endorsements. Garay EB; Rutkin AS J Healthc Risk Manag; 1997; 17(1):7-12. PubMed ID: 10167186 [No Abstract] [Full Text] [Related]
19. Advertising gone too far? Quinn C Mark Health Serv; 2008; 28(4):20-3. PubMed ID: 19157035 [No Abstract] [Full Text] [Related]
20. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health. Javitt GH; Stanley E; Hudson K Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034 [No Abstract] [Full Text] [Related] [Next] [New Search]